TGA seeks input on benzocaine advisory statements

0
The Therapeutic Goods Administration (TGA) has requested comments from interested parties on the addition of a new advisory statement for labels of non-prescription medicines...

Hot topics at the 2019 FIP Congress

0
Medicine access, technological disruption to traditional care models, ethical dilemmas and gender equity dominated the program for the 79th International Pharmacy Federation (FIP) Congress. The...

Weighing up options for osteoarthritis management

0
Osteoarthritis is a common condition that is expected to become even more prevalent by the end of the decade. Despite its commonness, our understanding of the disease has evolved to acknowledge inflammation as a mediator of degenerative changes and pain.

Dapagliflozin for infertility for women with obesity

This glucose-lowering diabetes drug may have therapeutic benefits and clinical utility for people with reproductive dysfunction.

Don’t forget about tuberculosis

0
TB is an infectious disease that has massive mortality globally; however, due to public health initiatives is mostly eradicated in Australia. Despite this, cases can still occur, and pharmacists should be aware of TB and its recommended treatment to ensure appropriate management.

Family business

0
Growing up, PSA’s 2023 Intern of the Year Grace Quach had more opportunity than most to see the difference pharmacists make to their patients.